🇺🇸 FDA
Patent

US 9085604

Antiproliferative factor and methods of use

granted A61KA61K38/00

Quick answer

US patent 9085604 (Antiproliferative factor and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/00